Menu
GeneBe

rs201751275

Variant summary

Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4

The NM_145207.3(SPATA5):c.1159C>T(p.Pro387Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000399 in 1,600,540 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00049 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00039 ( 3 hom. )

Consequence

SPATA5
NM_145207.3 missense

Scores

5
8
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:1

Conservation

PhyloP100: 7.09
Variant links:
Genes affected
AFG2A (HGNC:18119): (AFG2 AAA ATPase homolog A) This gene encodes a member of the ATPase associated with diverse activities family, whose members are defined by a highly conserved ATPase domain. Members of this family participate in diverse cellular processes that include membrane fusion, DNA replication, microtubule severing, and protein degradation. The protein encoded by this gene has a putative mitochondrial targeting sequence and has been proposed to function in maintenance of mitochondrial function and integrity during mouse spermatogenesis. Allelic variants in this gene have been associated with epilepsy, hearing loss, and cognitive disability syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -1 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.29436728).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SPATA5NM_145207.3 linkuse as main transcriptc.1159C>T p.Pro387Ser missense_variant 6/16 ENST00000274008.5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
AFG2AENST00000274008.5 linkuse as main transcriptc.1159C>T p.Pro387Ser missense_variant 6/161 NM_145207.3 P1Q8NB90-1
AFG2AENST00000422835.2 linkuse as main transcriptn.1201C>T non_coding_transcript_exon_variant 6/151
AFG2AENST00000675612.1 linkuse as main transcriptc.1156C>T p.Pro386Ser missense_variant 6/17
AFG2AENST00000674886.1 linkuse as main transcriptn.1221C>T non_coding_transcript_exon_variant 6/11

Frequencies

GnomAD3 genomes
AF:
0.000506
AC:
77
AN:
152040
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.000529
Gnomad OTH
AF:
0.00143
GnomAD3 exomes
AF:
0.000279
AC:
68
AN:
244076
Hom.:
1
AF XY:
0.000303
AC XY:
40
AN XY:
132080
show subpopulations
Gnomad AFR exome
AF:
0.0000622
Gnomad AMR exome
AF:
0.000652
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000206
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000260
Gnomad OTH exome
AF:
0.00186
GnomAD4 exome
AF:
0.000389
AC:
564
AN:
1448382
Hom.:
3
Cov.:
30
AF XY:
0.000382
AC XY:
275
AN XY:
720212
show subpopulations
Gnomad4 AFR exome
AF:
0.000517
Gnomad4 AMR exome
AF:
0.000616
Gnomad4 ASJ exome
AF:
0.0000391
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000229
Gnomad4 FIN exome
AF:
0.0000189
Gnomad4 NFE exome
AF:
0.000314
Gnomad4 OTH exome
AF:
0.00110
GnomAD4 genome
AF:
0.000493
AC:
75
AN:
152158
Hom.:
0
Cov.:
32
AF XY:
0.000538
AC XY:
40
AN XY:
74388
show subpopulations
Gnomad4 AFR
AF:
0.000337
Gnomad4 AMR
AF:
0.00118
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000208
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000529
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.000723
Hom.:
0
Bravo
AF:
0.000487
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000264
AC:
32

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitterclinical testingInstitute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU DresdenNov 03, 2021- -
Likely benign, criteria provided, single submitterclinical testingGeneDxDec 31, 2020- -
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMay 01, 2022- -
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingGenome-Nilou LabAug 10, 2021- -
Uncertain significance, criteria provided, single submitterclinical testingInvitaeOct 14, 2022This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 387 of the SPATA5 protein (p.Pro387Ser). This variant is present in population databases (rs201751275, gnomAD 0.06%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with SPATA5-related conditions. ClinVar contains an entry for this variant (Variation ID: 203535). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SPATA5 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 19, 2022The c.1159C>T (p.P387S) alteration is located in exon 6 (coding exon 6) of the SPATA5 gene. This alteration results from a C to T substitution at nucleotide position 1159, causing the proline (P) at amino acid position 387 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Benign
-0.026
T
BayesDel_noAF
Uncertain
0.090
Cadd
Uncertain
24
Dann
Uncertain
1.0
DEOGEN2
Benign
0.29
T
Eigen
Uncertain
0.58
Eigen_PC
Uncertain
0.60
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.96
D
M_CAP
Pathogenic
0.39
D
MetaRNN
Benign
0.29
T
MetaSVM
Pathogenic
1.0
D
MutationTaster
Benign
1.0
D
PrimateAI
Uncertain
0.63
T
PROVEAN
Pathogenic
-7.4
D
REVEL
Pathogenic
0.74
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.0030
D
Polyphen
0.12
B
Vest4
0.49
MVP
0.93
MPC
0.25
ClinPred
0.096
T
GERP RS
5.1
RBP_binding_hub_radar
1.0
RBP_regulation_power_radar
2.7
Varity_R
0.75
gMVP
0.82

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201751275; hg19: chr4-123856880; COSMIC: COSV99916424; API